Clinical Trial Update: Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial update for ceftobiprole in community-acquired and hospital-acquired pneumonia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Hospital-acquired Pneumonia

Drugs mentioned

• ceftobiprole (ceftobiprole)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Community-acquired Pneumonia (CAP), Hospital-acquired Pneumonia (HAP) | Phase 3 | Status: COMPLETED | Results posted: 2020-09-11